SAFETY AND EFFICACY OF SUNITINIB IN AN EXPANDED-ACCESS TRIAL OF METASTATIC RENAL CELL CARCINOMA (MRCC): UPDATED RESULTS AND SUBPOPULATION ANALYSIS
2008 ◽
Vol 7
(3)
◽
pp. 246
◽
2010 ◽
Vol 28
(2)
◽
pp. 231
2007 ◽
Vol 5
(4)
◽
pp. 299
◽
2011 ◽
Vol 47
◽
pp. S515
◽
2009 ◽
Vol 10
(8)
◽
pp. 757-763
◽